TTRX Announces Peer-Reviewed Publication Demonstrating GX-03 Reduces IL-36 Dermatitis Severity by 52% (p=0.0003) in Phase 2 Model
Turn Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.33
+2.2% in 1h after detection
Post-detection moves
1h
+2.2%
1d
+0.4%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS